Literature DB >> 23768966

Spinal ependymomas: benefits of extent of resection for different histological grades.

Michael C Oh1, Phiroz E Tarapore, Joseph M Kim, Matthew Z Sun, Michael Safaee, Gurvinder Kaur, Derick M Aranda, Andrew T Parsa.   

Abstract

Although the World Health Organization (WHO) categorizes spinal ependymomas into three histological grades, difference in surgical outcomes between WHO grades I and II tumors are unclear. For these benign tumors, prognosis may be best determined by factors other than tumor grade alone, such as extent of resection. To analyze the effects of the extent of resection on different grades of spinal ependymomas, we performed a comprehensive literature review to identify adult spinal ependymoma patients who received surgical resection with a clearly identifiable WHO grade. A total of 175 patients were identified. While grade III tumors carried the worst prognosis as expected (p<0.001), grade I and II tumors did not differ significantly in outcomes following surgery. Overall, gross total resection (GTR, 68.7%, 114/166) provided significantly improved progression-free survival (PFS, p<0.001) and overall survival (OS, p=0.022) compared to the subtotal resection group. Surprisingly, the highest GTR rate was achieved for grade II tumors (78.8%, 78/99; p<0.001) followed by grade I (58.9%, 33/56) and grade III tumors (27.3%, 3/11). Interestingly, PFS was significantly improved by GTR for grade II tumors (p<0.001), but not for grade I (p=0.705). Similar trends, although not statistically significant, were found for OS. Our results show that while GTR provides the best overall outcomes, GTR is most effective for classic grade II ependymomas, but not for grade I ependymomas. Despite having a lower WHO grade, myxopapillary ependymomas have a lower GTR rate, and benefit less from GTR.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ependymoma; Extent of resection; Recurrence; Spine; Tumor grade

Mesh:

Year:  2013        PMID: 23768966      PMCID: PMC4067248          DOI: 10.1016/j.jocn.2012.12.010

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  79 in total

1.  Ependymoma: a follow-up study of 101 cases.

Authors:  S J Mork; A C Loken
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

2.  Spinal cord ependymoma: radical surgical resection and outcome.

Authors:  Fadi Hanbali; Daryl R Fourney; Eric Marmor; Dima Suki; Laurence D Rhines; Jeffrey S Weinberg; Ian E McCutcheon; Ian Suk; Ziya L Gokaslan
Journal:  Neurosurgery       Date:  2002-11       Impact factor: 4.654

3.  Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients.

Authors:  A Helseth; S J Mørk
Journal:  J Neurosurg       Date:  1989-12       Impact factor: 5.115

4.  High failure rate in spinal ependymomas with long-term follow-up.

Authors:  Daniel R Gomez; Brian T Missett; William M Wara; Kathleen R Lamborn; Michael D Prados; Susan Chang; Mitchel S Berger; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

5.  Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.

Authors:  Scott R Plotkin; Caroline C O'Donnell; William T Curry; Catherine M Bove; Mia MacCollin; Fabio P Nunes
Journal:  J Neurosurg Spine       Date:  2011-02-04

6.  Spinal cord ependymomas: a retrospective analysis of 59 cases.

Authors:  J N Waldron; N J Laperriere; L Jaakkimainen; W J Simpson; D Payne; M Milosevic; C S Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-09-30       Impact factor: 7.038

7.  A case of cervicomedullary junction tanycytic ependymoma associated with marked cyst formation.

Authors:  Tamio Ito; Yoshimaru Ozaki; Jyoji Nakagawara; Hirohiko Nakamura; Shinya Tanaka; Kazuo Nagashima
Journal:  Brain Tumor Pathol       Date:  2005       Impact factor: 3.298

8.  Giant cell ependymoma of the spinal cord. Case report and review of the literature.

Authors:  Daryl R Fourney; Abdolreza Siadati; Janet M Bruner; Ziya L Gokaslan; Laurence D Rhines
Journal:  J Neurosurg       Date:  2004-01       Impact factor: 5.115

9.  Recurrent spinal ependymoma showing partial remission under Imatimib.

Authors:  N Fakhrai; P Neophytou; K Dieckmann; A Nemeth; D Prayer; J Hainfellner; C Marosi
Journal:  Acta Neurochir (Wien)       Date:  2004-09-13       Impact factor: 2.216

10.  Long term outcome with post-operative radiation therapy for spinal canal ependymoma.

Authors:  Sasha H Wahab; Joseph R Simpson; Jeff M Michalski; David B Mansur
Journal:  J Neurooncol       Date:  2007-01-06       Impact factor: 4.506

View more
  10 in total

1.  National trends in management of adult myxopapillary ependymomas.

Authors:  Daphne B Scarpelli; Claire B Turina; Patrick D Kelly; Arpine Khudanyan; Jerry J Jaboin; Shearwood McClelland
Journal:  J Clin Neurosci       Date:  2020-01-24       Impact factor: 1.961

2.  Natural history of intramedullary spinal cord ependymoma in patients preferring nonoperative treatment.

Authors:  Bedjan Behmanesh; Florian Gessler; Stephan Dützmann; Daniel Dubinski; Lioba Imoehl; Volker Seifert; Matthias Setzer; Gerhard Marquardt
Journal:  J Neurooncol       Date:  2017-06-30       Impact factor: 4.130

Review 3.  Spinal cord ependymoma: a review of the literature and case series of ten patients.

Authors:  Emma Celano; Arsalaan Salehani; James G Malcolm; Erik Reinertsen; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2016-05-06       Impact factor: 4.130

4.  Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.

Authors:  James E Bates; Gyujae Choi; Michael T Milano
Journal:  J Neurooncol       Date:  2016-06-15       Impact factor: 4.130

5.  Clinical outcomes of radiotherapy for spinal cord ependymoma with adverse prognostic features: a single-center study.

Authors:  Hwa Kyung Byun; Seong Yi; Hong In Yoon; Se Hoon Kim; Jaeho Cho; Chang-Ok Suh
Journal:  J Neurooncol       Date:  2018-09-10       Impact factor: 4.130

6.  Factors associated with postoperative outcomes in patients with intramedullary Grade II ependymomas: A Systematic review and meta-analysis.

Authors:  Xiang-Yao Sun; Wei Wang; Tong-Tong Zhang; Chao Kong; Si-Yuan Sun; Ma-Chao Guo; Jun-Zhe Ding; Shi-Bao Lu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

7.  Surgical outcome and prognostic factors in spinal cord ependymoma: a single-center, long-term follow-up study.

Authors:  Oliver Gembruch; Mehdi Chihi; Merle Haarmann; Ahmet Parlak; Marvin Darkwah Oppong; Laurèl Rauschenbach; Anna Michel; Ramazan Jabbarli; Yahya Ahmadipour; Ulrich Sure; Philipp Dammann; Neriman Özkan
Journal:  Ther Adv Neurol Disord       Date:  2021-11-10       Impact factor: 6.570

8.  Management and Outcome Analysis of Conus and Filum ependymoma: A Tertiary Center Study.

Authors:  Manoharan Dwark Sudhan; Guru Dutta Satyarthee; Leve Joseph; Mehar Chand Sharma; Aanchal Kakkar; Bhawani Shankar Sharma
Journal:  Asian J Neurosurg       Date:  2019 Jul-Sep

9.  A rare case of an intramedullary metastasis of a myxopapillary ependymoma.

Authors:  Lino Fonseca; Marta Cicuendez; Francisco Martínez-Ricarte; Elena Martínez-Saez; Esteban Cordero; Agustín Bescos
Journal:  Surg Neurol Int       Date:  2019-05-10

10.  Microsurgical Resection of Brain Stem Ependymoma: 2-Dimensional Operative Video.

Authors:  Mirza Pojskić; Vincent Nguyen; Goran Lakičević; Kenan I Arnautović
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-06-01       Impact factor: 2.703

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.